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Edited by Judit Ova´diAbstract The eﬀect of diﬀerent classes of dietary polyphenols
on intestinal glucose uptake was investigated using polarised
Caco-2 intestinal cells. Glucose uptake into cells under sodium-
dependent conditions was inhibited by ﬂavonoid glycosides and
non-glycosylated polyphenols whereas aglycones and phenolic
acids were without eﬀect. Under sodium-free conditions, agly-
cones and non-glycosylated polyphenols inhibited glucose uptake
whereas glycosides and phenolic acids were ineﬀective. These
data suggest that aglycones inhibit facilitated glucose uptake
whereas glycosides inhibit the active transport of glucose. The
non-glycosylated dietary polyphenols appear to exert their ef-
fects via steric hindrance, and ()-epigallochatechingallate,
()-epichatechingallate and ()-epigallochatechin are eﬀective
against both transporters.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Sodium-dependent glucose transporter 11. Introduction
Polyphenols are a complex group of chemicals that are
widely distributed throughout the plant kingdom and thus
form an integral part of the human diet [1,2]. It has been sug-
gested that dietary polyphenols protect against a variety of dis-
ease states including cancer and cardiovascular disease and, in
recent years, there has been an increased interest in these com-
pounds from both consumers and food manufacturers [3–5].
Ultimately, their biological eﬀects will depend on the extent
to which these substances and/or their metabolites interact
with cells [2].Abbreviations: SGLT1, sodium-dependent glucose transporter 1;
GLUT, facilitated diﬀusion glucose transporter; EGCG, ()-epigal-
lochatechingallate; EGC, ()-epigallochatechin; ECG, ()-epichate-
chingallate
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doi:10.1016/j.febslet.2004.12.099Our recent volunteer studies [6,7] have shown that ordinary
portions of certain beverages rich in dietary phenols may re-
sult in an altered pattern of intestinal glucose uptake. High
post-prandial plasma glucose concentrations are associated
with an increased risk of developing type II diabetes and
the metabolic syndrome [8,9] and any reduction in the post-
prandial glucose surge is potentially beneﬁcial. Reduced
glucose transport as a consequence of exposure to phenolic
compounds was ﬁrst shown by Nakazawa in 1922 [10] using
phloridzin, a ﬂavonoid glucoside. However, it was not until
1967 that Alvarado [11] demonstrated that this was due to
the competitive inhibition of sodium-dependent glucose trans-
port across the intestinal brush border membrane, which was
subsequently shown to be mediated via sodium-dependent
glucose transporter 1 (SGLT1). More recently, Koboyashi
et al. [12] have shown that the green tea polyphenols ()-
epigallochatechingallate (EGCG) and ()-epichatechingallate
(ECG) also inhibit glucose transport, possibly by SGLT1
inhibition, and Song et al. [13] have presented evidence for
a ﬂavonoid-mediated inhibition of the facilitated diﬀusion
glucose transporter 2 (GLUT2). In this respect it is interest-
ing to note that recent animal studies have suggested that
GLUT2 is responsible for a large proportion of glucose up-
take from the lumen of the small intestine [14–16].
Caco-2 cells have been widely used in studies to deter-
mine the transport kinetics and metabolism of dietary poly-
phenols [17–23], but have not been exploited to investigate
the eﬀects of dietary polyphenols on glucose transport.
Since these cells express abundantly both the facilitated glu-
cose transport proteins (GLUT 1 and 2) and SGLT1
[24] we have used them to screen polyphenols for interac-
tions with glucose transport pathways by measuring altera-
tions in glucose uptake under conditions that favour either
active transport (sodium-dependent) or facilitated transport
(sodium-free).2. Materials and methods
2.1. Cell culture
Stock cultures of Caco-2 cells (the TC7 subclone obtained from Drs.
Monique Rousset and Edith Brot-Laroche, INSERM U505, Paris,
France) were maintained in 25 cm2 plastic ﬂasks and cultured in a
95% air/5% CO2 atmosphere in Dulbeccos modiﬁed Eagles minimal
essential medium, supplemented with 20% heat-inactivated foetal bo-
vine serum, 1% penicillin/streptomycin, 1% non-essential amino acids
and 1% L-glutamine. All experiments were carried out on cells between
passage numbers 30 and 40. For experiments, cells were seeded at a
density of 1 · 104 cells/cm2 into six-well-plate inserts (Costar, UK,
Buckinghamshire, UK) and were grown for 19 days.ation of European Biochemical Societies.
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Glucose uptake assays were performed using HEPES buﬀered salt
solution 2 (HBSS, pH 7.5; 140 mM NaCl, 5 mM KCl, 1 mM Na2H-
PO4, 1 mM CaCl2, 0.5 mM MgCl2, 10 mM HEPES, and 0.2% bovine
serum albumin) containing 1 mM glucose and 100 lM of either the test
compound or the equimolar control (mannitol). D-[6-3H] Glucose was
used as the tracer and the ﬁnal amount of radioactivity in the control
or test solutions was 125 kBq per ml.
Caco-2 cells were placed in serum-free media for 24 h prior to uptake
studies and were incubated for 15 min at room temperature in HBSS
prior to experiments. Uptake was initiated by the addition of either
the control or test solutions and the reaction was terminated after
2 min by aspiration of the uptake buﬀer followed by the addition of
ice-cold PBS. Cells were washed twice more in ice-cold PBS and solu-
bilised overnight in 200 mM NaOH prior to scintillation counting.
2.3. Test compounds
The following compoundswere tested: (i) the dietary glycosides; arbu-
tin, naringin, neohesperidin dihydrochalcone, phloridzin and rutin;
(ii) the dietary phenolic acids; caﬀeic acid, chlorogenic acid (5-caﬀeoyl-
quinic acid (5-CQA)), ellagic acid, gallic acid, p-coumaric acid and feru-
lic acid; (iii) the model aglycones; apigenin, myricetin, phloretin and
quercetin (that do not normally occur in foods and beverages as agly-
cones but which may be released by hydrolysis in the gastro-intestinal
tract), and (iv) the non-glycosylated dietary polyphenols: (+)-catechin,
()-epicatechin, ()-epigallochatechin (EGC), ()-ECG, and ()-
EGCG (that normally occur in foods and beverages as aglycones).
2.4. Data analysis
Data are presented as the means ± S.E.M. Statistical analysis was
carried out using Graphpad Instat and normal distribution of the data
was conﬁrmed using Kolmogorov–Smirnovs one sample goodness-of-
ﬁt test. A one-sample t-test was performed for data obtained from each
individual six well plate, which consisted of two control wells and four
treatment wells. In order to correct for multiple comparisons, the level
of signiﬁcance (a-value) was reduced to P < 0.01.
2.5. Materials
D-[6-3H] Glucose was supplied by Amersham Pharmacia Biotech
UK Ltd., Buckinghamshire, UK. Cell culture medium and plasticware
were purchased from Life Technologies (Paisley, UK) unless stated.
Heat-inactivated foetal bovine serum was from Sigma Chemical Com-
pany (Poole, UK). All other chemicals were of highest grade available
and bought from Sigma, Merck or Fluka.B
Fig. 1. Glucose uptake in Caco-2 cells in the presence of dietary3. Results and discussion
It is well known that glucosides are substrates for Na+/glu-
cose co-transporters [25,26] expressed in a number of vectors
including Xenopus oocytes and Chinese hamster ovary cells
(CHO). Evidence is accumulating that dietary polyphenols
can be absorbed by the intestinal epithelium via interactions
with glucose transport proteins [27–30]. The aim of this study
was not to assess the absorption and bioavailability of dietary
polyphenols per se, but rather to investigate whether certain
polyphenols interfere with glucose transport and, if so, via
which transport mechanism(s). We have investigated the eﬀects
of selected dietary glycosides on glucose uptake in an intact
epithelial cell line under sodium-dependent conditions (favour-
ing uptake via SGLT1) and sodium-free conditions (favouring
uptake by GLUT proteins).
Under sodium-dependent conditions, neohesperidin dihydr-
ochalcone (P < 0.01) and phloridzin (P < 0.001) caused a2 When a sodium free buﬀer was required, NaCl and NaH2PO4 were
replaced with equimolar amounts of KCl and KH2PO4, respectively.marked and signiﬁcant reduction in glucose uptake when com-
pared with the control (Fig. 1A). The competitive inhibition of
SGLT1 by phloridzin has been well documented [31]. How-
ever, inhibition of sodium-dependent glucose uptake by neo-
hesperidin dihydrochalcone was not expected since other
rhamanoglucosides (e.g., rutin, see below) do not interact with
SGLT1 [27]. In addition, neohesperidin dihydrochalcone, due
to the rhamnose moiety, is not a substrate for the lumenally ex-
posed lactase–phloridzin hydrolase (LPH), ruling out lumenal
deglycosylation and interaction of the released aglycone with
the transporters. However, the fact that neohesperidin dihydr-
ochalcone exerts no eﬀect on glucose transport under sodium-
free conditions suggests that the inhibitory action of this
compound is not via an interaction with GLUT transport pro-
teins. It is possible, therefore, that under sodium-dependent
conditions hydrophobic interactions between neohesperidin
dihydrochalcone and the surrounding bilayer contribute to
the loss of active glucose transport.
Mean glucose uptake was also decreased with the other die-
tary glycosides tested, naringin, rutin and arbutin, but these ef-
fects did not reach statistical signiﬁcance. Previous studies
have suggested that naringin [32] and rutin [29] do not have
a major inﬂuence on intestinal glucose uptake. However, the
glucoside arbutin (that caused a 23% reduction in sodium-
dependent glucose uptake) is transported by SGLT1 in
hamster tissue [33] and in Xenopus oocytes [25], and its con-
sumption has been associated with arbutin-diabetes [34].
None of the dietary glycosides tested had any eﬀect on glucose
transport under sodium-free conditions that favour facilitated
(i.e., GLUT-mediated) transport (Fig. 1B).glycosides under both sodium-dependent (A) and sodium-free condi-
tions (B). Results are expressed as means ± S.E.M. (N = 4). Under
sodium-dependent conditions there were signiﬁcant reductions in
cellular glucose uptake in wells treated with neohesperidin dihydroch-
alcone (\P < 0.01) and phloridzin (\\P < 0.001) only. None of the ﬁve
test compounds had any eﬀect under sodium-free conditions.
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icant eﬀect on glucose uptake under either sodium-dependent
or sodium-free conditions (data not shown). This is in contrast
to the work by Welsch et al. [35] who showed that caﬀeic, feru-
lic and chlorogenic acid (5-CQA) all caused an inhibition in so-
dium-dependent glucose uptake by rat brush border
membrane vesicles. A likely explanation for the discrepancies
in these observations is the diﬀerences in the ratio of test sub-
stance to substrate. In our experiments, the phenolic acids were
present at 1/10 the concentration of the substrate (i.e., 100 lM
phenolic acid versus 1 mM glucose). However, Welsch and
coworkers used a 20-fold excess of inhibitor compared with
the substrate. Interestingly, other in vivo studies using rodent
models have suggested a role for various hydroxycinnamic
acids as anti-hyperglycaemic agents. Hsu et al. [36] observed
a dose-dependent decrease in plasma glucose concentrations
in streptozotocin-induced diabetic rats after intravenous
administration of a caﬀeic acid extract. Similarly, 5-CQA-
containing plant extracts lowered plasma glucose levels in strep-
tozotocin-induced diabetic rats to a level comparable with that
of the reference compound glibenclamide [37]. These observa-
tions suggest a possible role for these compounds in regulation
of plasma glucose concentrations, although the eﬀects appear to
be the result of direct action on peripheral tissue rather than via
a blockade of glucose uptake across the intestinal BBM. How-
ever, since unpuriﬁed extracts were used, it is not possible to as-
sign the eﬀects to any particular component(s).
Selected aglyconeswere tested because phloretin, the aglycone
of phloridzin, is a known inhibitor of sodium-independent glu-B
A
Fig. 2. Glucose uptake in Caco-2 cells in the presence of model
aglycones under both sodium-dependent (A) and sodium-free condi-
tions (B). Results are expressed as means ± S.E.M. (N = 4). There were
no signiﬁcant reductions in cellular glucose uptake under sodium-
dependent conditions. However, under sodium-free conditions, there
were signiﬁcant reductions in cellular glucose uptake in wells treated
with phloretin (\P < 0.01), apigenin (\\\P < 0.0005), and quercetin and
myricetin (\\\\P < 0.0001).cose transport [38]. In the absence of sodium, each of the agly-
cones tested caused a statistically signiﬁcant reduction in
glucose uptake when compared with the control (Fig. 2B). The
most eﬀective was myricetin (82% reduction), followed by quer-
cetin (75% reduction), phloretin (47% reduction) and apigenin
(39% reduction). Although quercetin may occur as the aglycone
in some matured red wines [39] these compounds are not gener-
ally found at an appreciable level in the diet, but some can be re-
leased from certain glycosides by lumenal [40] or microbial
hydrolases [41–44]. The model aglycones had no eﬀect on glu-
cose uptake under Na+-dependent conditions (Fig. 2A).
The ﬁnal group of compounds tested were the non-glycosyl-
ated dietary polyphenols (Fig. 3). All test compounds caused a
signiﬁcant reduction in glucose uptake under sodium-depen-
dent conditions (Fig. 3A). Under sodium-free conditions,
EGCG, EGC and ECG caused a reduction in glucose uptake
(37%, 60% and 65%, respectively) but in contrast both (+)-cat-
echin and ()-epicatechin resulted in a small but non-signiﬁ-
cant increase in glucose uptake compared with the control
(Fig. 3B). The non-glycosylated polyphenols have been shown
to reduce glucose uptake signiﬁcantly under sodium-dependent
conditions in vivo in animals [45], in vitro using animal tissues
[12] and also using a Xenopus oocyte expression vector [46].
Furthermore, a crude extract of tea was shown to inhibit the
intestinal absorption of glucose and sodium in rats although
the relative contribution of the individual components in-
volved was not determined [47] and more recently, an instantA
B
Fig. 3. Glucose uptake in Caco-2 cells in the presence of non-
glycosylated dietary polyphenols under both sodium-dependent (A)
and sodium-free conditions (B). Results are expressed as mean-
s ± S.E.M. (N = 4). Under sodium-dependent conditions, there were
signiﬁcant reductions in cellular glucose uptake in wells treated with
(+)-catechin, ()-epicatechin, EGCG, EGC (\\\P < 0.0005) and ECG
(\\\\P < 0.0001). Under sodium-free conditions, there were signiﬁcant
reductions in cellular glucose uptake in wells treated with EGCG
(\\\P < 0.0005), and EGC and ECG (\\\\P < 0.0001).
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tulated to have similar eﬀects in healthy human subjects [48].
Under sodium-free conditions, only those compounds contain-
ing both a 3,4,5-trihydroxy benzene residue (in either the ﬂav-
anol B-ring or the galloyl residue) had a signiﬁcant inhibitory
eﬀect on glucose uptake. However, under sodium-dependent
conditions, this structural feature was not required since both
(+)-catechin and ()-epicatechin with 3,4-dihydroxy B-rings
signiﬁcantly reduced glucose uptake. The eﬀects of EGCG,
ECG and EGC are likely to be the result of steric hindrance
caused by incorporation into the membrane with subsequent
disruption of the surrounding lipid-bilayer as shown previ-
ously by [46] using transfected Xenopus oocytes as an expres-
sion vector.
Recent evidence has suggested that GLUT2, in addition to
SGLT1, may have a major role in mediating intestinal glucose
transport across the brush border membrane of enterocytes
[14–16]. Our in vitro data indicate the potential for a variety
of classes of dietary polyphenols to aﬀect intestinal glucose
transport in vivo by both transporters simultaneously. Fur-
thermore, these data suggest that foods and unsweetened bev-
erages rich in these dietary polyphenols might provide a
convenient dietary mechanism for regulating the rate of intes-
tinal sugar absorption that is an important factor in the man-
agement of diabetes, and in the long-term oﬀer some
protection against developing the metabolic syndrome or type
II diabetes.
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